AN OPEN-LABEL INTERNATIONAL PHASE III STUDY OF THE LONG-TERM SAFETY OF LIPROTAMASE FOR TREATMENT OF PANCREATIC INSUFFICIENCY IN CF

被引：0
|
作者：
Borowitz, D. [1 ]
Stevens, C. [2 ]
Fratazzi, C. [2 ]
Cohen, D. [2 ]
Campion, M. [2 ]
机构：
[1] SUNY Buffalo, Womens & Childrens Hosp, Dept Pediat, Buffalo, NY 14260 USA
[2] Alnara Pharmaceut Inc, Cambridge, MA USA
来源：
PEDIATRIC PULMONOLOGY | 2009年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
520
引用
收藏
页码：397 / 398
页数：2
相关论文
共 50 条
  • [21] Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan
    Inoue, Yushi
    Ohtsuka, Yoko
    EPILEPSY RESEARCH, 2015, 113 : 90 - 97
  • [22] Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability
    Montgomery, Stuart
    Emir, Birol
    Haswell, Hannah
    Prieto, Rita
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (10) : 1223 - 1230
  • [23] An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia
    Ohta, Hiroyoshi
    Oka, Hiroshi
    Usui, Chie
    Ohkura, Masayuki
    Suzuki, Makoto
    Nishioka, Kusuki
    MODERN RHEUMATOLOGY, 2013, 23 (06) : 1108 - 1115
  • [24] Treatment interruption did not impact efficacy or long-term safety of dupilumab: A phase 3 open-label trial
    Beck, L. A.
    Mette, D.
    Zhang, Q.
    Akinlade, B.
    Staudinger, H.
    Graham, N.
    Pirozzi, G.
    Ardeleanu, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S43 - S43
  • [25] Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension study
    Lai, Wyman W.
    Galer, Bradley S.
    Wong, Pierre C.
    Farfel, Gail
    Pringsheim, Milka
    Keane, Martin G.
    Agarwal, Anupam
    EPILEPSIA, 2020, 61 (11) : 2386 - 2395
  • [26] Long-term olanzapine therapy in the treatment of bipolar I disorder: An open-label continuation phase study
    Sanger, TM
    Grundy, SL
    Gibson, PJ
    Namjoshi, MA
    Greaney, MG
    Tohen, MF
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (04) : 273 - 281
  • [27] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [28] An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia
    Murakami, Masato
    Osada, Kenichi
    Ichibayashi, Hisao
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Ishida, Mitsuhiro
    Alev, Levent
    Nishioka, Kusuki
    MODERN RHEUMATOLOGY, 2017, 27 (04) : 688 - 695
  • [29] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2390 - I2392
  • [30] Long-term safety of zonisamide in children with epilepsy: A multicentre, open-label extension study
    Rosenfeld, W.
    Glauser, T.
    Levisohn, P.
    Frank, L. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 89 - 89
12345